Cargando…

THU296 Effect Of Tirzepatide In GADA-positive Individuals With T2D: A Post Hoc Analysis Of The SURPASS 2-5 Trials

Disclosure: A.L. Peters: Advisory Board Member; Self; Abbott Diabetes Care, Eli Lilly & Company, Medscape, Novo Nordisk, Zealand. Grant Recipient; Self; Dexcom, Insulet Corporation. Stock Owner; Self; Omada Health, Teladoc. Other; Self; Abbott Diabetes Care. R. Buzzetti: Consulting Fee; Self; Sa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Peters, Anne L, Buzzetti, Raffaella, Eun Lee, Clare Jung, Pavo, Imre, Liu, Minzhi, Paik, Jim S
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Diabetes And Glucose Metabolism
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10555850/ http://dx.doi.org/10.1210/jendso/bvad114.731

Ejemplares similares

OR28-4 Efficacy and Safety of Tirzepatide Versus Semaglutide in a Hispanic or Latino Population: A Prespecified Subgroup Analysis of SURPASS-2
por: Benneyworth, Brian D, et al.
Publicado: (2022)

THU255 Tirzepatide-induced Weight Loss In A Type 2 Diabetic Taking Oral Contraceptives
por: Arunachalam, Amar, et al.
Publicado: (2023)

OR03-1 Achievement of HbA1c <6.5% without weight gain and hypoglycemia in people with type 2 diabetes treated with tirzepatide across the phase 3 SURPASS program
por: Allen, Sheryl Elaine, et al.
Publicado: (2022)

THU244 Clinical Factors Affecting Dapagliflozin Response For Glycemic Control And Body Weight Reduction: Post-hoc Analysis Of BEYOND Study
por: Jeung Ahn, Kyu, et al.
Publicado: (2023)

FRI643 Tirzepatide Associated Partial Small Bowel Obstruction: A Case Report
por: Mathew, Anoopa, et al.
Publicado: (2023)

FRI612 Tirzepatide For The Treatment Of Post-bariatric Surgery Hypoglycemia And Early Dumping Syndrome
por: Frederick Stortz, Ethan, et al.
Publicado: (2023)

THU376 Isotretinoin Related DKA In Type 2 Diabetes
por: Radovanovic, Natasa, et al.
Publicado: (2023)

THU263 Intestinal Production of H(2)S And Its Regulation Of GLP-2
por: Hammond, Joel, et al.
Publicado: (2023)

THU387 Euglycemic Diabetic Ketoacidosis And SGLT-2 Inhibitor Use
por: Abrahimi, Nora, et al.
Publicado: (2023)

THU360 Hyperglycemic DKA In Patient On Monotherapy With SGLT-2 Inhibitor
por: Ahmed, Samihah, et al.
Publicado: (2023)

THU372 Finasteride Induced Hyperglycemia
por: Bose, Vivek, et al.
Publicado: (2023)

THU389 Euglycemic Diabetic Ketoacidosis With Prolonged Ketosis Due To SGLT-2 Inhibitor
por: Viera Feliciano, Natalia, et al.
Publicado: (2023)

THU247 Characterizing Inpatient Cases Of DKA Precipitated By SGLT2 Inhibitor Use
por: Aslamy, Arianne, et al.
Publicado: (2023)

THU295 The Role Of Imatinib In Pediatric Diabetes
por: Lavelle, Kristen, et al.
Publicado: (2023)

THU282 Improved Fournier’s Gangrene Outcomes With Prior SGLT2i Or Metformin Usage
por: Venugopal, Sharini, et al.
Publicado: (2023)

THU291 Successful Reversal Of Glucose Toxicity After DKA Precipitated By SGLT2 Inhibitor
por: Abdelrahman, Houda, et al.
Publicado: (2023)

THU302 Protective Effects Of Lactation On Maternal Metabolism
por: Hens, Julie R, et al.
Publicado: (2023)

THU354 Enfortumab Vedotin Induced Refractory Hyperglycemia
por: Hussein, Marwah, et al.
Publicado: (2023)

THU359 A Classical Case Of SGLT-2 Inhibitor Euglycemic Ketoacidosis In A Patient With Glucotoxicity
por: Amankwah, Samuel, et al.
Publicado: (2023)

THU371 Empagliflozin Associated Pancreatitis: A Case Report
por: Poloju, Alekya, et al.
Publicado: (2023)

THU348 Thyroid Dysfunction And Diabetes In Pregnancy - Is There A Link?
por: Kumar Sahay, Rakesh, et al.
Publicado: (2023)

THU325 Covid-19 Outcomes In Cancer Patients With Diabetes
por: Tan Ngo, Emmeline Monique, et al.
Publicado: (2023)

THU260 Development Of Plantar Thermography For Screening Of Diabetic Neuropathy
por: Panamonta, Vipawee, et al.
Publicado: (2023)

THU310 A Presentation Of Diabetic Ketoacidosis In Gestational Diabetes
por: Yim, Carly, et al.
Publicado: (2023)

THU347 Diffusion Tensor Imaging Of The Tibial Nerve Can Detect Peripheral Neuropathy In Type 2 Diabetes
por: Park, Hyeong-Kyu, et al.
Publicado: (2023)

THU378 Presentation Of Autoimmune Destruction Of Pancreatic Beta Cells By Pembrolizumab In The Setting Of Existing Type 2 Diabetes
por: Seidenberg, Jacob, et al.
Publicado: (2023)

THU355 Tingling Over Cheek, An Atypical Presentation Of Invasive Fungal Sinusitis In An Ambulatory Patient With Type 2 Diabetes
por: Udayasankar, Jayalakshmi, et al.
Publicado: (2023)

THU285 Predictive Factors Of Response To Liraglutide In Long-standing Type 2 Diabetes: A Real-life Study
por: Romero, Fabiola, et al.
Publicado: (2023)

THU270 Efficacy Of Patient Support Program On Management Of Cardiovascular Risk Factors For Adults With Type 2 Diabetes Mellitus
por: Shah, Abhishek, et al.
Publicado: (2023)

THU007 Improving Completeness Of Endocrinology Referrals Using Structured Templates
por: Arao, Kevin, et al.
Publicado: (2023)

THU306 Association Of Prediabetes With Cardiovascular Outcomes Among Veterans With Obesity
por: Pendse, Jay, et al.
Publicado: (2023)

THU356 Muscle Pain In A Diabetic: Think Outside The Box
por: Ellangovan, Rithikaa, et al.
Publicado: (2023)

THU346 Repairing Skeletal Deterioration In Diabetes With Bone Anabolic Therapies
por: Marino, Silvia, et al.
Publicado: (2023)

THU276 The Use of Continuous Glucose Monitors for Management of Postbariatric Hypoglycemia
por: Jani, Shivani, et al.
Publicado: (2023)

THU261 Etiologic Factors, Contributors, And Associations For Exocrine Pancreatic Insufficiency
por: Romo, Karina G, et al.
Publicado: (2023)

THU264 Enteric Activity Enhanced Ileal GLP-1 Secretion
por: Chen, Yixin, et al.
Publicado: (2023)

THU373 Refractory Hypoglycemia In A Patient With Metastatic Cholangiocarcinoma: Abstract
por: Gabriela Fernandez, Maria, et al.
Publicado: (2023)

THU280 Acute Interstitial Nephritis- A Complication Of Semaglutide Use
por: Alsayed Hasan, Marah, et al.
Publicado: (2023)

THU301 Natural History Of Pregnancy And Pregnancy Outcomes In Subjects With Lipodystrophy
por: Neal, Trinity J, et al.
Publicado: (2023)

Effects of Tirzepatide Versus Insulin Glargine on Cystatin C–Based Kidney Function: A SURPASS-4 Post Hoc Analysis
por: Heerspink, Hiddo J.L., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_kb3dmld0pkcr9skvinfso33ukr